NSEOutcome of Board Meeting4d ago · 3 Nov 2026, 07:58 pm
Outcome of Board Meeting
Laxmi Dental Limited · LAXMIDENTL
✦ AI SummaryResults
Laxmi Dental Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, and has approved the same at its board meeting held on November 03, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Laxmi Dental Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Attachments (1)
📄pdf
Download →
LAXMI_03112026195702_Binder_2.pdf
View document text
LAXM I DENT AL LIMITED
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058.
Tel: 022 61437991 | Email: info@laxmidentallimited.com; co.sec@laxmidentallimited.com | Website: www.laxmidentallimited.com
CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL
Date: November 03, 2026
Listing Department Listing & Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block
BSE Scrip Code: 544339 Bandra-Kurla Complex
Bandra (E), Mumbai – 400 051
Symbol: LAXMIDENTL
Dear Sir(s)/Madam(s),
Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020
Subject: Outcome of Board Meeting held today i.e. Tuesday, November 03, 2026.
Ref: Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 30 and Regulation 33 read with Part A of Schedule III of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended from time to time (“SEBI Listing Regulations”), we wish to inform
you that the Board of Directors, at its meeting held today i.e., Tuesday, November 03, 2026, inter-alia, has considered and
approved the following:
1. Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended
September 30, 2026 (Q2/H1FY26-27);
In terms of the provisions of Regulation 30 and 33 of the SEBI Listing Regulations, we are enclosing herewith the copy
of following as Annexure-1:
a. Unaudited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30,
2026; and
b. Limited Review Report on the said Unaudited Financial Results (Consolidated and Standalone) received from
the Statutory Auditors of the Company for the said period.
The meeting of the Board of Directors commenced at 04:00 P.M. (IST) and concluded at 05:10 P.M. (IST).
The same will be made available on the Company’s website, i.e. https://laxmidentallimited.com/for-investors#financial.
Kindly take the same on your record.
For Laxmi Dental Limited
--------------------------------------------------
Suman Saha
Company Secretary and Compliance Officer
ICSI Membership Number: A33035
Encl.: As above
MSKA & Associates LLP HO
602, Floor 6, Raheja Titanium
(Formerly known as MS KA ft Associates) Western Express Highway, Geetanjali
Railway Colony, Ram Nagar, Goregaon (E)
Chartered Accountants
Mumbai 400063, INDIA
Tel: +91 22 6974 0200
Independent Auditor's Review Report on consolidated unaudited financial results of Laxmi Dental
Limited for the quarter and year to date pursuant to the Regulation 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended
To the Board of Directors of Laxmi Dental Limited
1 . We have reviewed the accompanying Statement of consolidated unaudited financial results of Laxmi
Dental Limited (hereinafter referred to as 'the Holding Company'), its subsidiaries, (the Holding
Company and its subsidiaries together referred to as the 'Group') and its share of the net profit after
tax and total comprehensive income of its jointly controlled entities for the quarter ended September
30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 ('the
Statement') attached herewith, being submitted by the Holding Company pursuant to the requirements
of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended ('the Regulations').
2. This Statement, which is the responsibility of the Holding Company's Management and approved by the
Holding Company's Board of Directors, has been prepared in accordance with the recognition and
measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting'
prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued
thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is
in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement
based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review Engagements
(SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the
Entity' issued by the Institute of Chartered Accountants of India. A review of interim financial
information consists of making inquiries, primarily of persons responsible for financial and accounting
matters, and applying analytical and other review procedures. A review is substantially less in scope
than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of
the Act and consequently does not enable us to obtain assurance that we would become aware of all
significant matters that might be identified in an audit. Accordingly, we do not express an audit
opinion.
We also performed procedures in accordance with the circular issued by the Securities and Exchange
Board of India under Regulation 33 (8) of the Regulations, to the extent applicable.
4. This Statement includes the results of the Holding Company and the following entities:
Sr. No Name of the Entity Relationship with the Holding Company
1. Bizdent Devices Private Limited Wholly owned subsidiary of Holding Company
2. Signature Smile Dental Clinic Subsidiary of Holding Company (88.88%)
Private Limited
3. Rich Smile Design LLP Subsidiary of Holding Company (66.00%)
4. Laxmi Dental Lab USA INC. Wholly owned subsidiary (71.43% owned by
Holding Company and 28.57% owned by Bizdent
Devices Private Limited)
5. Diverse Dental Lab I NC. Subsidiary of Laxmi Dental Lab USA INC. (85.00%)
Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India
Tel: +91 22 6974 0200 I LLPIN: ACT-3789
Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Pune www.mska.in
MSKA & Associates LLP
(Formerly known as MS KA & Associates)
Chartered Accountants
6. Illusion Dental Lab USA INC Wholly owned Subsidiary of Laxmi Dental Lab USA
INC.
7. KlDS-E-Dental LLP Joint Venture of Holding Company (60.00%)
8. IDBG Al Dent Global Private Limited Joint Venture of Holding Company (49.00%)
5. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has
come to our attention that causes us to believe that the accompanying Statement prepared in
accordance with the recognition and measurement principles laid down in Ind AS 34 and other
recognised accounting principles generally accepted in India has not disclosed the information required
to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that
it contains any material misstatement.
6. We did not review the interim financial information of five subsidiaries included in the Statement,
before giving effect to the consolidation adjustments, whose interim financial information reflects
total assets of Rs. 258.68 million as at September 30, 2026 and total revenues of Rs. 175.53 million and
Rs. 332.55 million, total net profit after tax of Rs.28.40 million and Rs. 45.97 million and total
comprehensive income of Rs.30.73 million and Rs.47.93 million , for the quarter ended September 30,
2026 and for the period from April 01, 2026 to September 30, 2026, respectively, and cash flows (net)
of Rs. 7.42 million for the period from April 01, 2026 to September 30, 2026, as considered in the
Statement. These interim financial information have been reviewed by other auditor whose reports
have been furnished to us by the Management and our conclusion on the Statement, in so far as it
relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the
report of the other audit
[Showing first 8,000 characters — download PDF for full document]